01 — At a Glance
A Company That Bought Trouble & Called It Strategy
- Q3 FY26 Revenue₹2,103 Cr
- Q3 FY26 PAT-₹116 Cr
- Q3 FY26 EPS-₹14.67
- 9M FY26 Revenue₹7,097 Cr
- 9M FY26 PAT-₹78.8 Cr
- Book Value₹448
- Price to Book1.86x
- Net Debt₹10.8 Cr
- Debt / Equity0.72x
- 52W Return-13.1%
The Plot Twist: Sudarshan bought Heubach Group for €230 million (₹1,900 crore) in Oct 2024. By Q1 FY26 (June 2025), the acquired business was supposed to help them become the 2nd largest pigment producer globally. By Q3 (Dec 2025), it was a €38 crore EBITDA loss, destocking nightmares in Europe, and tariff drama in the US. Also: they’re firing people and reducing inventory on purpose. They literally told investors this will make reported EBITDA worse before it gets better. Clarity? Or PTSD from a ₹90 crore Labour Code provision?
02 — Introduction
The Pigment Dealer’s Dream (Turned Nightmare)
Sudarshan Chemical is the third-largest pigment manufacturer globally. For 70 years, they painted things red, blue, yellow, and occasionally brown. Margins were decent. Life was simple. Revenue grew at 14% CAGR over five years. Return on Equity was in the double digits. Shareholders were, dare we say, content.
Then, in October 2024, they woke up and decided to acquire the entire pigment business of Heubach Group — a 140-year-old German chemical company that had recently gone bankrupt due to weak demand and cost mismanagement.
The rationale? Create a “global powerhouse.” The reality? Within three months, the company was posting losses, invoking labour law provisions, and asking investors to ignore EBITDA because “we’re doing cash-destructive things on purpose” (inventory reduction, folks).
Q3 FY26 was supposed to show integration progress. Instead, it delivered: Q3 PAT of -₹116 crore, negative EPS of -₹14.67, and management saying “the worst is behind us” with the kind of conviction you’d have if you were a taxi driver in 2008 saying “the housing crisis is priced in, bhai.”
This is not a red flag. This is a red flag factory.
From the Feb 2026 Concall: “We did not want them to experience any issues in supplies, so that it builds back the trust.” Management literally held massive inventory (good inventory, they claim) to prove they won’t ghost customers like Heubach did during insolvency. Meanwhile, customers are destocking. So Sudarshan is holding inventory while customers reduce theirs. Economics of love, apparently.
03 — Business Model: We Paint Things (Used To)
The Two-Head Monster That Isn’t Working
Legacy Sudarshan: Manufactures organic pigments (azo, phthalos, high-performance pigments), inorganic pigments, and effect pigments. Serves coatings, plastics, inks, textiles, cosmetics, automotive sectors. Domestic market share: 35%. Two plants in India (Roha, Mahad). Revenue FY25: ~₹5.3 billion. EBITDA margins: 12–16% historically. Profit EBITDA to 3.8 billion in FY25. Life was good.
Post-Heubach Sudarshan: Now owns 19 manufacturing facilities across 11 countries, 5 continents. 1,600+ pigment products, 63 brands, 4,000+ direct customers. Global market position: supposedly 2nd-largest now. But: the acquired business had revenues of ~€1 billion pre-crisis, with 9%-11% EBITDA margins. Then demand collapsed, costs exploded, and it went bankrupt.
So what did Sudarshan buy? A business that was generating EUR 90-100 million EBITDA pre-crisis, now generating EUR 0 (at best, they hope for EUR 35 million in FY26). The turnaround plan: shift production to India (cheaper labour, utilities), implement ERP unification (they were running 4 SAP systems), and pray demand recovers.
Also: RIECO Industries, Sudarshan’s engineering subsidiary, lost money for two years, then posted positive EBITDA of ₹4.2 crore for 9M FY26 (vs -₹20 crore for 9M FY25). Baby steps, apparently.
Management’s Framing on Inventory Reduction: “This is all good inventory… not selling… at any discount.” Translation: we’re not desperate. We’re strategically burning cash. Over the next three quarters, they’ll release EUR 30–40 million in inventory, which will trigger EUR 9–12 million in overhead absorption hits to EBITDA. So reported EBITDA will look worse before it gets better. This is not a bug. This is a feature.
💬 If you held ₹1,000 worth of Sudarshan shares before the Heubach acquisition, would you have stayed invested? Or would you have screamed into your pillow?
04 — Financials Overview: The Bleeding Begins
Q3 FY26: When Losses Aren’t Just Numbers
